OncoZenge AB (publ) ("OncoZenge" or "the Company"), a pharmaceutical company developing an innovative treatment for oral pain relief, today announced a new collaboration with the University of ...

Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg ...

A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers-which affect parts of the body involved in reproduction and excretion-in middle aged adults, suggests ...

Kidney injury molecule–1 (KIM-1) has emerged as a potential prognostic biomarker for response to therapy and could be used to ...

Despite marijuana’s Schedule I status, which classifies it as having no accepted medical use, hundreds of studies in the past ...

New research indicates that individuals living with dementia are being treated with potent antipsychotic medications for ...

Fasting and ketogenic diets were found to benefit blood fats, weight, and blood pressure in MS, but did not reduce brain ...

Anderson Center for Health Systems Excellence at Cincinnati Children’s. Cincinnati Children’s is ranked among the best pediatric health systems in the nation by U.S. News & World Report, including No.

CBT-I Is the evidence-based first-line treatment, but access gaps persist.

A drug called riluzole, commonly used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases, could ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart failure with preserved ejection fraction.The study investigated the effectiveness ...